Loading...

Home
Stock
BEAM

BEAM News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Forecast Technical Valuation Financials Earnings Should I Buy News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

BEAM News

Beam Therapeutics Executive Sells Shares

Feb 01 2026Fool

Wall Street Focuses on Earnings and Commodity Prices

Jan 29 2026stocktwits

ARK Invest Deepens AI Chip and Gene Editing Investments, Sells 86K Tesla Shares

Jan 19 2026seekingalpha

BEAM Options Analysis: Put Contract Offers 11.29% YieldBoost

Jan 13 2026NASDAQ.COM

Beam Therapeutics (BEAM) to Submit Biologics License Application for Risto-cel by End of 2026

Jan 12 2026stocktwits

Beam Therapeutics Outlines 2026 Strategy, Shares Surge 23.67%

Jan 12 2026Benzinga

Bank Stocks Decline Broadly; Capital One Drops 6% Following Trump's Rate Cap Proposal

Jan 12 2026CNBC

Planet Labs PBC Secures Nine-Figure Deal with Swedish Armed Forces, Shares Surge 7%

Jan 12 2026Benzinga

BEAM Events

Beam Therapeutics Stock Rises 27.9% to $35.24

Beam Therapeutics is up 27.9%, or $7.69 to $35.24.

BEAM Monitor News

Beam Therapeutics Aligns with FDA on Accelerated Approval for BEAM-302

BEAM Earnings Analysis

No Data

No Data

People Also Watch